Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.735 USD | +1.09% | -8.92% | +28.95% |
05-23 | Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating | MT |
05-14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
28.87M | - | - | - | - | - | |
63.85B | - | |||||
41.83B | ||||||
40.65B | ||||||
27.12B | ||||||
26.52B |